Menu Close

Trending

Why reshoring drug production means embracing continuous manufacturing
Clariness, DailyBreath partner to drive recruitment in asthma trials
J&J says it will stop selling all talc products next year
Cumulus’ gamified dry EEG system tops lab monitoring in trial
Dismay as UK ‘drags its heels’ on AZ’s COVID antibody Evusheld

Genomics England

Genomics-England

Cancer/ Market Access/ News/ News/ News/ News/ Oncology/ R&D/ Sales and Marketing

AI specialists join Genomics England’s drug discovery alliance

, 0 Comment

Lantern Pharma, a pharma company which uses artificial intelligence to develop shelved oncology drugs has joined Genomics England’s groundbreaking industry partnership.

X
AI specialists join Genomics England’s drug discovery alliance
https://pharmaphorum.com/news/ai-specialists-join-genomics-englands-drug-discovery-alliance/
South Korea Flag is Waving Against Blue Sky

Digital/ Healthcare/ News/ News/ Oncology

South Korea hopes big data will boost life sciences industry

, , , , 0 Comment

South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.

X
South Korea hopes big data will boost life sciences industry
https://pharmaphorum.com/digital/south-korea-hopes-big-data-will-boost-life-sciences-industry/
Molecular, DNA and atom model in science research lab

Healthcare/ Patients/ R&D/ R&D/ UK & Europe/ Views & Analysis/ Views & Analysis/ Views and analysis

A world leader in genomics, but England’s patients face obstacles to tests

, , 0 Comment

England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.

X
A world leader in genomics, but England’s patients face obstacles to tests
https://pharmaphorum.com/views-analysis-patients/world-leader-genomics-englands-patients-face-obstacles-tests/

Login

CONTINUE TO SITE >
X
Close in 10 seconds